Live·Verified funding discovery · 2026.2
882 grants · 20 open · 435 companies · 2640 concepts882 / 20 / 435 / 2640
GRANTDocumentary Production · Screen Australia closes 24 SEPTGRANTInstitutional Development Award (IDeA) for Clinical & Translational Research · National Institute of General Medical Sciences (NIGMS), National Institutes of Health closes 25 SEPTCOMPANIESCompanies rated · 435 (no change)PROJECTSProjects rated · 70 (no change)CATALOGUE882 grants in catalogue · 20 open right nowPOWERED BYOpen Longevity · 501(c)(3) · Sherman Oaks, CAGRANTDocumentary Production · Screen Australia closes 24 SEPTGRANTInstitutional Development Award (IDeA) for Clinical & Translational Research · National Institute of General Medical Sciences (NIGMS), National Institutes of Health closes 25 SEPTCOMPANIESCompanies rated · 435 (no change)PROJECTSProjects rated · 70 (no change)CATALOGUE882 grants in catalogue · 20 open right nowPOWERED BYOpen Longevity · 501(c)(3) · Sherman Oaks, CA
← Back to Eternal Search
David Whelan

David Whelan

vc
Fund operator

About

David Whelan is a healthcare venture investor and company builder best known as Co-Founder and General Partner of Town Hall Ventures, a New York VC firm focused on underserved U.S. healthcare populations. Before Town Hall, he was Managing General Partner of the Oxeon Venture Studio and earlier served as CFO and General Partner at Accretive LLC, plus prior operating and banking roles at Virgin Group and Goldman Sachs. I found no reliable public evidence connecting him to Propelx; the strongest public identification is with Town Hall Ventures and Oxeon.

Areas of interest

healthcarehealth equityunderserved communitiesMedicareMedicaidvalue-based carecare deliverykidney carebehavioral healthoncology caresenior careAI in healthcaremedication intelligencesocial care infrastructurespecialty pharmacy